SCHEMBL2013516

SCHEMBL2013516

CN(C(=O)c1cnc2ccccc2c1)C(CCNC(=O)c1cccn1C)Cc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.66
HCRTR2 O43614 2/20 0.66
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
CFTR P13569 1/20 0.45
TRPM8 Q7Z2W7 3/20 0.40
GABRA1 P14867 1/20 0.40
CCR1 P32246 1/20 0.39
HTR1A P08908 2/20 0.39
DRD2 P14416 2/20 0.39
HTR2A P28223 2/20 0.39
HTR2C P28335 2/20 0.39
DRD3 P35462 2/20 0.39
CCKBR P32239 1/20 0.38
GCGR P47871 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
TNKS O95271 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6918071 1.00 HCRTR1 (0.66) HCRTR1HCRTR2NPC1RAB9ACFTR
SCHEMBL2013785 0.90 HCRTR1 (0.67) HCRTR1HCRTR2NPC1RAB9ACCR1
SCHEMBL2013183 0.86 HCRTR1 (0.61) HCRTR1HCRTR2NPC1RAB9ACCR1
SCHEMBL13139060 0.85 HCRTR1 (0.77) HCRTR1HCRTR2NPC1RAB9AHTR1A
SCHEMBL2012310 0.85 HCRTR1 (0.67) HCRTR1HCRTR2NPC1RAB9ATRPM8
SCHEMBL2011910 0.85 HCRTR1 (0.69) HCRTR1HCRTR2NPC1RAB9AHDAC3
SCHEMBL2013519 0.84 HCRTR1 (0.68) HCRTR1HCRTR2NPC1RAB9AHDAC3
SCHEMBL2049210 0.84 HCRTR1 (0.68) HCRTR1HCRTR2NPC1RAB9AHDAC3
SCHEMBL2012507 0.84 HCRTR1 (0.68) HCRTR1HCRTR2NPC1RAB9AHDAC3
SCHEMBL2053280 0.84 HCRTR1 (0.68) HCRTR1HCRTR2NPC1RAB9AHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed